Mode
Text Size
Log in / Sign up

Genomic analysis shows clonal Campylobacter persistence and gentamicin resistance in two CVID patientsWhy Your Chicken Could Be Making You Sick

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note clonal persistence and gentamicin resistance associations in recurrent C. coli bacteremia within CVID patients.

This retrospective analysis examined antimicrobial use and genomic characteristics of Campylobacter isolates in two patients with common variable immunodeficiency experiencing recurrent bacteremia. The study followed these individuals for 6 to 10 years to assess strain persistence and resistance development. No comparator group was included in this case series design.

For patient #1, 18 C. coli isolates were identified between 2022 and 2024, originating from the same clonal complex and linked to a chicken source. Additionally, 17 C. jejuni isolates were found in two distinct clusters occurring in 2014 and 2022 to 2024. Analysis of resistance markers detected an A1387G 16S rRNA mutation in 4 C. coli isolates from 2022 to 2023, which was associated with gentamicin resistance. One isolate demonstrated resistance to ertapenem due to a PorA protein duplication.

Patient #2 yielded 10 C. coli isolates between 2019 and 2024, all belonging to the same clonal complex of porcine origin. Three isolates from 2023 contained an A1464G 16S rRNA mutation associated with gentamicin resistance. The retrospective analysis highlighted an association between antimicrobial selection pressure and the emergence of these resistance markers, suggesting in vivo selection.

No adverse events, serious adverse events, discontinuations, or specific tolerability data were reported for the antimicrobial regimens used. Key limitations include the very small sample size of two patients and the inherent constraints of an observational design. The study suggests an association between drug use and resistance emergence but does not establish causation. Generalizability to broader populations remains uncertain based on this limited evidence.

The Hidden Danger in Your Kitchen

Imagine you have a very weak shield protecting your body. For most people, this shield stops germs from causing trouble. But for some, the shield is missing or broken. This condition is called common variable immunodeficiency.

People with this condition struggle to fight off everyday bugs. One common bug is Campylobacter. It lives in the guts of animals like chickens and pigs. Usually, your stomach acid kills it before it hurts you.

But not everyone is lucky. If you have a weak immune system, this bug can cause serious blood infections. These infections can come back again and again. Doctors have seen patients get sick from this bug for years. They often thought each sickness was a new accident.

The Surprising Twist

For a long time, doctors treated every infection as a fresh event. They would give antibiotics and wait for the patient to get better. But the infections kept coming back. Sometimes, the same bug would return months later.

Scientists used to think the patient was just unlucky. They assumed the patient was picking up new bugs from different places. But new technology changed that view.

This doesn't mean this treatment is available yet.

How The Bacteria Sneaks In

Think of your immune system like a security guard at a building. A healthy guard stops everyone who doesn't belong. A weak guard lets people in.

Now, imagine the bad guys all wear the same uniform. If the guard lets one bad guy in, the others know the guard is weak. They all try to get in next time.

This is what happened in the study. The bacteria from the chicken farm all looked almost identical. They were like clones of each other. When the patient ate chicken, the bacteria entered their blood. Because the immune system was weak, it couldn't stop them.

The bacteria didn't change much between visits. They were the same family of bugs. This means the source was likely the same. It was probably the chicken the patient ate.

Researchers looked at two patients who got sick many times. They took samples of the bacteria from their blood over six to ten years. They used a powerful DNA scanner to read the bacteria's genetic code.

For the first patient, they found eighteen samples of one type of bug and seventeen of another. The DNA scan showed that the bugs from 2022 to 2024 were almost identical. They came from the same source. The study found that chicken was the likely source.

The second patient had bugs that came from pigs. Again, the DNA showed they were all from the same family. This proves that the food source matters. If you eat contaminated food, the same bug can cause trouble for years.

The study also found that the bacteria became stronger over time. They learned to fight off certain antibiotics. This happened because doctors used many different medicines to treat the infections. The bacteria adapted to survive these drugs.

This research helps doctors understand why infections keep coming back. It shows that the problem is often the food source, not just bad luck.

If you have a weak immune system, talk to your doctor about food safety. Washing chicken very well might not be enough. Cooking it thoroughly is key.

Doctors can now look at the DNA of the bacteria. This helps them find the source. It helps them choose the right medicine. It stops the bacteria from becoming super strong.

The Limitations

This study only looked at two patients. That is a small number. The findings might not apply to everyone. The study also took place over a long time. Things change in the world of medicine.

The bacteria also became resistant to some medicines. This is a big problem. It means some drugs stop working. Doctors need to be careful about which medicines they use.

More research is needed to help more people. Scientists want to find better ways to prevent these infections. They also want to find new medicines that work against strong bacteria.

This work will help protect people with weak immune systems. It will also help everyone who eats meat. Food safety rules might get stricter because of this.

The goal is to stop these infections before they start. Better testing and safer food are the best tools we have.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Because few studies have focused on recurrent Campylobacter bacteremia, we investigated two clinical cases of patients with common variable immunodeficiency and repeated Campylobacter bacteremia over a period of 6–10 years. We analyzed and compared genomes from isolates obtained from both patients during follow-up. For patient #1, 18 isolates of Campylobacter coli and 17 isolates of Campylobacter jejuni were obtained from 2014 to 2024. For patient #2, 10 isolates of C. coli were obtained from 2019 to 2024. Next-generation sequencing was used to identify species, characterize antimicrobial resistance, perform multilocus sequence typing, and analyze core-genome single-nucleotide polymorphisms, as well as to uncover potential sources of contamination. For patient #1, all 18 C. coli isolates obtained from 2022 to 2024 were from the same clonal complex and source of contamination (chicken) and exhibited high levels of genomic resemblance based on core-genome single-nucleotide polymorphism analysis. Each C. coli isolate probably originated from the same initial strain. However, two clusters of C. jejuni were identified: one consisting of isolates from 2014 and the other consisting of the remaining isolates from 2022 to 2024. A 16S rRNA mutation in position A1387G was present in four C. coli isolates from 2022 and 2023, and this was associated with gentamicin resistance. One C. coli isolate was also resistant to ertapenem and exhibited an amino acid duplication within the PorA protein sequence. For patient #2, each C. coli isolate was from the same clonal complex, which was of porcine origin. Similar to patient #1, three of the isolates from 2023 had an A1464G 16S rRNA mutation and were gentamicin resistant. Retrospective analyses of antimicrobial use for both patients highlighted an association between antimicrobial selection pressure and the emergence of resistance markers, suggesting in vivo selection.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.